STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 95 filers reported holding STOKE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.14 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,062 | -59.8% | 100 | -68.5% | 0.00% | – |
Q1 2023 | $2,640 | +164.0% | 317 | +65.1% | 0.00% | – |
Q4 2022 | $1,000 | -75.0% | 192 | -40.0% | 0.00% | – |
Q3 2022 | $4,000 | 0.0% | 320 | 0.0% | 0.00% | – |
Q2 2022 | $4,000 | -33.3% | 320 | 0.0% | 0.00% | – |
Q1 2022 | $6,000 | -14.3% | 320 | +3.2% | 0.00% | – |
Q4 2021 | $7,000 | -12.5% | 310 | +3.3% | 0.00% | – |
Q3 2021 | $8,000 | -20.0% | 300 | 0.0% | 0.00% | – |
Q2 2021 | $10,000 | -16.7% | 300 | 0.0% | 0.00% | – |
Q1 2021 | $12,000 | -36.8% | 300 | 0.0% | 0.00% | – |
Q4 2020 | $19,000 | +90.0% | 300 | 0.0% | 0.00% | – |
Q3 2020 | $10,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |